» Articles » PMID: 32265300

Knock-in Rats with Homozygous Alzheimer Mutation Are Viable and Show Selective γ-secretase Activity Loss Causing Low Aβ40/42 and High Aβ43

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2020 Apr 9
PMID 32265300
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Familial forms of Alzheimer's disease (FAD) are caused by mutations in the gene encoding amyloid precursor protein, whose processing can result in formation of β-amyloid (Aβ). FAD can also result from mutations in the () genes, whose protein products partially compose the γ-secretase complex that cleaves Aβ from amyloid precursor protein fragments. KO mice and knock-in (KI) mice with homozygous FAD-associated L435F mutations ( ) are embryonic and perinatally lethal, precluding a more rigorous examination of the effect of Alzheimer's disease-causing mutations on neurodegeneration. Given that the rat is a more suitable model organism with regard to surgical interventions and behavioral testing, we generated a rat KI model of the mutation. In this study, we focused on young rats to determine potential early pathogenic changes caused by this mutation. We found that, unlike mice, rats survive into adulthood despite loss of γ-secretase activity. Consistent with loss of γ-secretase function, rats exhibited low levels of Aβ38, Aβ40, and Aβ42 peptides. In contrast, levels of Aβ43, a longer and potentially more amyloidogenic Aβ form, were significantly increased in and rats. The longer survival of these KI rats affords the opportunity to examine the effect of homozygous Alzheimer's disease-associated mutations on neurodegeneration in older animals.

Citing Articles

siRNA drug delivery across the blood-brain barrier in Alzheimer's disease.

Sajid M, Sultan Sheikh F, Anis F, Nasim N, Sumbria R, Nauli S Adv Drug Deliv Rev. 2023; 199:114968.

PMID: 37353152 PMC: 10528676. DOI: 10.1016/j.addr.2023.114968.


Familial Alzheimer's disease-associated PSEN1 mutations affect neurodevelopment through increased Notch signaling.

Hurley E, Mozolewski P, Dobrowolski R, Hsieh J Stem Cell Reports. 2023; 18(7):1516-1533.

PMID: 37352850 PMC: 10362499. DOI: 10.1016/j.stemcr.2023.05.018.


Aβ43 levels determine the onset of pathological amyloid deposition.

Tambini M, Yin T, Yesiltepe M, Breuillaud L, Zehntner S, dAbramo C J Biol Chem. 2023; 299(7):104868.

PMID: 37257821 PMC: 10404620. DOI: 10.1016/j.jbc.2023.104868.


Late-long-term potentiation magnitude, but not Aβ levels and amyloid pathology, is associated with behavioral performance in a rat knock-in model of Alzheimer disease.

Yesiltepe M, Yin T, Tambini M, Breuillaud L, Zehntner S, DAdamio L Front Aging Neurosci. 2022; 14:1040576.

PMID: 36438008 PMC: 9691854. DOI: 10.3389/fnagi.2022.1040576.


Initial assessment of the spatial learning, reversal, and sequencing task capabilities of knock-in rats with humanizing mutations in the Aβ-coding region of App.

Pham H, Yin T, DAdamio L PLoS One. 2022; 17(5):e0263546.

PMID: 35507596 PMC: 9067689. DOI: 10.1371/journal.pone.0263546.


References
1.
Fanutza T, Prete D, Ford M, Castillo P, DAdamio L . APP and APLP2 interact with the synaptic release machinery and facilitate transmitter release at hippocampal synapses. Elife. 2015; 4:e09743. PMC: 4755753. DOI: 10.7554/eLife.09743. View

2.
Borchelt D, Thinakaran G, Eckman C, Lee M, Davenport F, Ratovitsky T . Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron. 1996; 17(5):1005-13. DOI: 10.1016/s0896-6273(00)80230-5. View

3.
Tamayev R, DAdamio L . Inhibition of γ-secretase worsens memory deficits in a genetically congruous mouse model of Danish dementia. Mol Neurodegener. 2012; 7:19. PMC: 3407505. DOI: 10.1186/1750-1326-7-19. View

4.
Veugelen S, Saito T, Saido T, Chavez-Gutierrez L, De Strooper B . Familial Alzheimer's Disease Mutations in Presenilin Generate Amyloidogenic Aβ Peptide Seeds. Neuron. 2016; 90(2):410-6. DOI: 10.1016/j.neuron.2016.03.010. View

5.
Haapasalo A, Kovacs D . The many substrates of presenilin/γ-secretase. J Alzheimers Dis. 2011; 25(1):3-28. PMC: 3281584. DOI: 10.3233/JAD-2011-101065. View